Leader Biomedical Group

Contributing to the global healthcare community and extending the reach of patients and caregivers

About Us

Our purpose

Contributing to the betterment of the global healthcare community with proven solutions and continuous innovation

 

Our promise

Extending the reach of patients and caregivers by improving global access to reliable, targeted therapeutic solutions and new technologies

LB_aboutus_journey_201801

Leader Biomedical is committed to improving global access to innovative biomaterials and implantable medical devices and extending the reach of patients and caregivers. We contribute to the betterment of the healthcare sector by developing new technologies, delivering world-class contract manufacturing, and providing healthcare solutions.

Our Journey

Foundation
Prof. Lugee Li is the founder and sole shareholder of Leader Biomedical Group. Originally a materials engineer, Prof. Lugee Li is the Founder and Chairman of Dongguan Eontec, a new materials company listed on the Shenzen Stock exchange In 2016 he acquired a majority interest in Liquid Metal Technologies, which is listed on the NASDAQ. Prof. Lugee Li currently heads China’s magnesium research initiate, teaming up with German companies to investigate the applications of magnesium in the medical field; it is this initiative that inspired his entry into the field of medical devices

2014: Acquisition of EMCM and formation of Leader Biomedical Group
Subsequent to the acquisition of EMCM, Leader Biomedical Group was formed with headquarters in Amsterdam, the Netherlands to support the future growth and strategy of the business

2015: Establishment of LB Brazil and LB India
Leader Biomedical expanded its reach with the establishment of Leader Biomedical Brazil, in Sao Paulo to initiate registration activities for its line of bone cements in this market, and Leader Biomedical India, in Bangalore to improve the country’s access to Total Hip and Knee Arthroplasty products

2016: Further increase of Leader Biomedical Group’s global reach
In its pursuit to improving global access to innovative bone graft substitutes and extending the reach of patients and caregivers, Leader Biomedical Group partners with BioTiss Austria in a new eCOO® Technology manufacturing venture and establishes two more regional ventures with Leader Biomedical RUS, in Moscow, Russian Federation, and Leader Biomedical ASIA PACIFIC SDN BHD (Leader Biomedical APAC), in Selangor, Malaysia

2017: Expansion into United States
In our commitment to further increase our downstream value chain and support our vision to continuously improve global access to next generation healthcare, Leader Biomedical Group establishes a venture with Leader Biomedical USA LLC in Schaumburg, USA, starting with sales activities of our synthetic bone substitures line OssGro® and our patented eCOO® Technology

2018: Expansion into Germany
Leader Biomedical enters into a strategic partnership with International Orthopeadics in Geisingen, Germany, focusing on our bringing our orthopaedics solutions to this market.

More info

We’re happy to answer any questions you may have, contact us.

Contact